SS Innovations International (NASDAQ: SSII) is expanding its SSi Mantra surgical robotic platform from an established base in India into international markets, with growth reflected in both revenue and system installations. The company reported second-quarter revenue of $13.9 million, a 39.4% increase year over year, and installed 30 systems during the quarter. That brought its total installed base to 224 systems across 12 countries as of June 30, 2026, with more than 12,000 cumulative procedures performed.
The expansion matters because surgical robotics has long been dominated by a handful of expensive systems, limiting access in many parts of the world. SS Innovations positions its technology as affordable and accessible, supporting specialties including cardiac, urology, gynecology, general and thoracic surgery. The company is also developing telesurgery capabilities, which could extend surgical expertise to remote locations. For investors and the medical industry, the numbers suggest that demand for cost-effective robotic surgery is real and growing.
SSII’s growth opportunity extends beyond its current markets. The company is pursuing U.S. FDA 510(k) clearance and European CE marking, which could substantially broaden its addressable market. Those regulatory milestones, if achieved, would allow SS Innovations to compete in the world’s largest healthcare markets, where robotic surgery adoption is high but equipment costs remain a barrier. For patients, broader competition could mean more hospitals can offer robotic procedures, potentially improving access and reducing costs.
To view the full article, visit https://nnw.fm/zbfTI. The latest news and updates relating to SSII are available in the company’s newsroom at https://nnw.fm/SSII.
SS Innovations International develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. Its product range includes the proprietary SSi Mantra surgical robotic system and the comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly and cost-effective surgical robotic solutions.
The announcement was distributed through NetworkNewsWire, a specialized communications platform focused on financial news and content distribution. NetworkNewsWire is one of 75+ brands within the Dynamic Brand Portfolio at IBN. The platform provides access to wire solutions through InvestorWire, as well as editorial syndication to 5,000+ outlets, press release enhancement, social media distribution and a full array of tailored corporate communications solutions.
For the medical robotics sector, SS Innovations’ progress highlights a shift toward more affordable systems that could challenge established players. As the company works toward U.S. and European clearances, its ability to replicate its India success in new markets will be a key indicator of whether cost-effective robotic surgery can gain global traction.
